Stay updated on Risankizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing v3.3.1 in the page footer; the change is cosmetic and does not affect the study content or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:39:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Publications section updated to note that publications are automatically filled from PubMed and may not be about the study (Revision: v3.3.1). The previous PubMed listing description was removed and replaced with the new wording (Revision: v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-24T14:38:56.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Removed the government funding status notice from the page; core study content and key details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T06:58:26.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    No substantive changes were observed; the screenshots show only minor layout adjustments with no changes to study content, eligibility criteria, or dates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:21:20.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    1%
    Check dated 2025-10-05T10:13:02.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page has been updated to indicate a new version (v3.1.0) and removes several older MedlinePlus topics (drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) along with the previous revision note (v3.0.2).
    Difference
    0.2%
    Check dated 2025-09-28T03:17:20.000Z thumbnail image

Stay in the know with updates to Risankizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.